Dr. Paul Robert Rhodes is a Oakland, California based Periodontics who is specialized in Periodontology. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Paul Robert Rhodes is 16821 for Periodontology in California. His current practice location is 6130 Skyline Blvd, Oakland. Patients can reach him at 510-595-4101.
Dr. Paul Robert Rhodes is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Dr. Paul Robert Rhodes speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1407086242
NPI Enumeration Date:
14 Jul, 2009
NPI Last Update On:
14 Jul, 2009
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Paul Robert Rhodes are as mentioned below.
License Number
Specialization
State
Status
16821
Periodontology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6130 Skyline Blvd, Oakland, California
Zip:
94611-1062
Phone Number:
510-595-4101
Fax Number:
510-903-9241
Patients can reach Dr. Paul Robert Rhodes at 6130 Skyline Blvd, Oakland, California or can call to book an appointment on 510-595-4101. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.